Clinical Outcomes of Perioperative Immunotherapy in Resectable Non–Small Cell Lung Cancer

This retrospective cohort study found that chemoimmunotherapy was associated with favorable clinical DMFS outcomes in patients with resectable NSCLC. The findings highlight the need to address barriers to broader adoption of chemoimmunotherapy.